# Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

> **NCT01520818** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 666 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 50
- **DRUG:** biphasic insulin aspart 70
- **DRUG:** biphasic human insulin 30

## Key facts

- **NCT ID:** NCT01520818
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2001-04
- **Final completion:** 2001-04
- **Target enrollment:** 666 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520818, "Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01520818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*